US 10781181
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
granted A61KA61K31/415A61K31/416
Quick answer
US patent 10781181 (N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors) held by KalVista Pharmaceuticals Limited expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/415, A61K31/416, A61K31/4439, A61K31/4709